Balasa Dinverno & Foltz LLC Novo Nordisk A S Transaction History
Balasa Dinverno & Foltz LLC
- $1.58 Billion
- Q3 2022
A detailed history of Balasa Dinverno & Foltz LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Balasa Dinverno & Foltz LLC holds 3,169 shares of NVO stock, worth $440,079. This represents 0.02% of its overall portfolio holdings.
Number of Shares
3,169
Previous 3,139
0.96%
Holding current value
$440,079
Previous $350,000
9.71%
% of portfolio
0.02%
Previous 0.02%
Shares
6 transactions
Others Institutions Holding NVO
# of Institutions
1,859Shares Held
310MCall Options Held
5.29MPut Options Held
4.93M-
Jennison Associates LLC21.1MShares$2.93 Billion1.82% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa13.7MShares$1.91 Billion0.83% of portfolio
-
Bank Of America Corp Charlotte, NC13.1MShares$1.81 Billion0.16% of portfolio
-
Morgan Stanley New York, NY12MShares$1.67 Billion0.13% of portfolio
-
Fayez Sarofim & CO Houston, TX11.8MShares$1.64 Billion4.6% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $313B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...